These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 31031831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M, Yan X, Wu W.
    BMC Cardiovasc Disord; 2021 Sep 17; 21(1):446. PubMed ID: 34535088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
    He M, Gong Y, Shi J, Pan Z, Zou H, Sun D, Tu X, Tan X, Li J, Li W, Liu B, Xue J, Sheng L, Xiu C, Yang N, Xue H, Ding X, Yu C, Li Y.
    PLoS One; 2014 Sep 17; 9(11):e112043. PubMed ID: 25427155
    [Abstract] [Full Text] [Related]

  • 10. Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation.
    Liang H, Cui Y, Bu H, Liu H, Yan P, Cui L, Chen L.
    Exp Ther Med; 2020 Jul 17; 20(1):211-218. PubMed ID: 32536993
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.
    Rizzacasa B, Morini E, Mango R, Vancheri C, Budassi S, Massaro G, Maletta S, Macrini M, D'Annibale S, Romeo F, Novelli G, Amati F.
    PLoS One; 2019 Jul 17; 14(5):e0216363. PubMed ID: 31059534
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.
    Yuan L, Dong J, Zhu G, Bao J, Lu Q, Zhou J, Jing Z.
    Sci Rep; 2019 Feb 04; 9(1):1402. PubMed ID: 30718561
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yıldırım E, Çelik M, Yüksel UÇ, Buğan B, Gökoğlan Y, Görmel S, Yaşar S, Koklu M, İyisoy A, Barçın C.
    Turk Kardiyol Dern Ars; 2017 Dec 04; 45(8):702-708. PubMed ID: 29226890
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A, Murat SN, Yarlioglues M, Duran M, Karadeniz M, Ergun G, Akyel A, Mendi MA, Oksuz F.
    Platelets; 2015 Dec 04; 26(1):48-52. PubMed ID: 24831828
    [Abstract] [Full Text] [Related]

  • 20. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
    Yoshimura M, Umemoto S, Kawano R, Hiromoto M, Yamada M, Fujimura T, Tanaka M, Nao T, Miura T, Yano M.
    Int Heart J; 2021 Dec 04; 62(5):970-979. PubMed ID: 34588411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.